27 more hESC lines approved

National Institutes of Health (NIH) director Francis Collins linkurl:approved 27 more human embryonic stem cell lines;http://grants.nih.gov/stem_cells/registry/current.htm as eligible for federal funding on Monday, bringing the total number of new lines to 40 -- almost double the number of previously okayed lines under the administration of former President George W. Bush. Human embryonic stem cellsImage: Wikimedia commons, Nissim Benvenisty"I am hopeful that this will be an important boost to

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
National Institutes of Health (NIH) director Francis Collins linkurl:approved 27 more human embryonic stem cell lines;http://grants.nih.gov/stem_cells/registry/current.htm as eligible for federal funding on Monday, bringing the total number of new lines to 40 -- almost double the number of previously okayed lines under the administration of former President George W. Bush.
Human embryonic stem cells
Image: Wikimedia commons,
Nissim Benvenisty
"I am hopeful that this will be an important boost to the healing work envisioned by the National Institutes of Health in its support of this field of research," Collins said in a statement. However, Collins has limited the federal funding of these lines to the use specifically stated on the consent forms: diabetes-related pancreatic research. The move came after a committee advising the NIH director linkurl:recommended that 27 of 28 lines;http://www.the-scientist.com/blog/display/56204/ -- all part of a single submission from Harvard University -- be approved with such limitations. Consent for the derivation of the 28th line came during a lapse in the institution's IRB, and thus was not recommended for approval. As of yet, the NIH has not responded to the committee's request for guidelines addressing the broader use of embryos derived for a specific purpose.
**__Related stories:__***linkurl:27 more hESC lines head for OK;http://www.the-scientist.com/blog/display/56204/
[4th December 2009]*linkurl: NIH OKs 13 stem cell lines;http://www.the-scientist.com/blog/display/56196/
[2nd December 2009]*linkurl:NIH picks stem cell panel;http://www.the-scientist.com/blog/display/55991/
[21st September 2009]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours